Clinical trials in ALS: an overview. by Turner, M, Parton, M, Leigh, P

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. by Turner, M, Parton, M, Shaw, C, Leigh, P, Al-Chalabi, A

Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. by Hilton-Jones, D, Miller, A, Parton, M, Holton, J, Sewry, C, Hanna, MG

The natural history of sporadic inclusion body myositis: development of an electronic database IBMnet by Miller, A, Machado, P, Morrow, J, Hiscock, A, Dewar, L, Brady, S, Hilton-Jones, D, Hanna, MG, Parton, M

The Natural History of Sporadic Inclusion Body Myositis-an Observational Longitudinal Study. by Machado, P, Cortese, A, Morrow, J, Dewar, L, Hiscock, A, Miller, A, Brady, S, Hilton-Jones, D, Parton, M, Hanna, MG

CLINICAL FEATURES AND CLINICAL COURSE OF SPORADIC INCLUSION BODY MYOSITIS (IBM): A PROSPECTIVE COHORT STUDY: IBM-NET by Cortese, A, Machado, P, Miller, A, Brady, S, Hilton-Jones, D, Morrow, J, Hiscock, A, Dewar, E, Parton, M, Hanna, M

Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials. by Cortese, A, Machado, P, Morrow, J, Dewar, L, Hiscock, A, Miller, A, Brady, S, Hilton-Jones, D, Parton, M, Hanna, MG

Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials by Cortese, A, Machado, P, Morrow, J, Dewar, L, Hiscock, A, Miller, A, Brady, S, Hilton-Jones, D, Parton, M, Hanna, MG

The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study by Cortese, A, Machado, P, Morrow, J, Dewar, L, Hiscock, A, Miller, A, Brady, S, Hilton-Jones, D, Parton, M, Hanna, MG

Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations. by Jaffer, F, Reilly, M, Quinlivan, R, Muntoni, F, Turner, C, Parton, M, Lunn, M, Hilton-Jones, D, Korkodilos, M, Hanna, MG

Tubular aggregates and cylindrical spirals have distinct immunohistochemical signatures by Brady, S, Healy, E, Gang, Q, Parton, M, Quinlivan, R, Jacob, S, Curtis, E, Al-Sarraj, S, Sewry, C, Hanna, M, Houlden, H, Beeson, D, Holton, J

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. by Al-Chalabi, A, Scheffler, MD, Smith, B, Parton, M, Cudkowicz, M, Andersen, P, Hayden, D, Hansen, V, Turner, M, Shaw, C, Leigh, P, Brown, R

A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease. by Graham, C, Weinman, J, Sadjadi, R, Chalder, T, Petty, R, Hanna, MG, Turner, C, Parton, M, Maddison, P, Radunovic, A, Longman, C, Robb, Y, Bushby, K, Hilton-Jones, D, Rose, MR

Clinical features of the myasthenic syndrome arising from mutations in GMPPB by Rodríguez Cruz, P, Belaya, K, Basiri, K, Sedghi, M, Farrugia, M, Holton, J, Liu, W, Maxwell, S, Petty, R, Walls, T, Kennett, R, Pitt, M, Sarkozy, A, Parton, M, Lochmüller, H, Muntoni, F, Palace, J, Beeson, D

Atypical periodic paralysis and myalgia: A novel RYR1 phenotype by Matthews, E, Neuwirth, C, Jaffer, F, Scalco, RS, Fialho, D, Parton, M, Rayan, D, Suetterlin, K, Sud, R, Spiegel, R, Mein, R, Houlden, H, Schaefer, A, Healy, E, Palace, J, Quinlivan, R, Treves, S, Holton, JL, Jungbluth, H, Hanna, MG

Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing by Schuh, A, Dreau, H, Knight, SJL, Ridout, K, Mizani, T, Vavoulis, D, Colling, R, Antoniou, P, Kvikstad, EM, Pentony, MM, Hamblin, A, Protheroe, A, Parton, M, Shah, KA, Zsolt, O, Athanasou, N, Hassan, B, Flanagan, AM, Ahmed, A, Winter, S, Harris, A, Tomlinson, I, Popitsch, N, Church, DN, Taylor, JC